Matches in Nanopublications for { ?s ?p "[We hypothesized that variants of GFPT1 encoding glutamine-fructose-6-phosphate amidotransferase, the rate limiting enzyme in this pathway, could increase GFPT1 gene expression and thus susceptibility to diabetes and diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP421452.RAAFvghEmJ03DdthquWqCbX83wCjKM-BYndGrnA2yokck130_assertion description "[We hypothesized that variants of GFPT1 encoding glutamine-fructose-6-phosphate amidotransferase, the rate limiting enzyme in this pathway, could increase GFPT1 gene expression and thus susceptibility to diabetes and diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421452.RAAFvghEmJ03DdthquWqCbX83wCjKM-BYndGrnA2yokck130_provenance.
- NP225678.RAoWIkbQeNIZy3L_MNXw7kiCpYK2xCc272HfQ5zZF8HsU130_assertion description "[We hypothesized that variants of GFPT1 encoding glutamine-fructose-6-phosphate amidotransferase, the rate limiting enzyme in this pathway, could increase GFPT1 gene expression and thus susceptibility to diabetes and diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225678.RAoWIkbQeNIZy3L_MNXw7kiCpYK2xCc272HfQ5zZF8HsU130_provenance.